Table 2.
Treatment group | Dosage (mg/kg) | Gastric emptying (%) | Intestinal transit (%) |
---|---|---|---|
Normal | CMC-Na | 62.93 ± 8.74 | 64.16 ± 7.00 |
WCA | 1600 | 45.85 ± 5.63** | 70.58 ± 4.07* |
ALR | 200 | 66.78 ± 9.70 | 52.78 ± 6.16* |
ALR | 400 | 64.24 ± 6.96 | 48.07 ± 5.96* |
ALR | 800 | 59.74 ± 9.81 | 42.82 ± 3.82** |
ANOVA followed by Dunnett’s multiple comparison test.
Compared with neostigmine mice:
*p < 0.05.
**p < 0.01.